Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vladimir Sarnavka is active.

Publication


Featured researches published by Vladimir Sarnavka.


Proceedings of the National Academy of Sciences of the United States of America | 2004

S-adenosylhomocysteine hydrolase deficiency in a human: A genetic disorder of methionine metabolism

Ivo Barić; Ksenija Fumić; B. Glenn; Mario Ćuk; Andreas Schulze; James D. Finkelstein; S. Jill James; Vlatka Mejaški-Bošnjak; Leo Pažanin; Igor P. Pogribny; Marko Radoš; Vladimir Sarnavka; Mira Šćukanec-Špoljar; Robert H. Allen; Sally P. Stabler; Lidija Uzelac; Oliver Vugrek; Conrad Wagner; Steven H. Zeisel; S. Harvey Mudd

We report studies of a Croatian boy, a proven case of human S-adenosylhomocysteine (AdoHcy) hydrolase deficiency. Psychomotor development was slow until his fifth month; thereafter, virtually absent until treatment was started. He had marked hypotonia with elevated serum creatine kinase and transaminases, prolonged prothrombin time and low albumin. Electron microscopy of muscle showed numerous abnormal myelin figures; liver biopsy showed mild hepatitis with sparse rough endoplasmic reticulum. Brain MRI at 12.7 months revealed white matter atrophy and abnormally slow myelination. Hypermethioninemia was present in the initial metabolic study at age 8 months, and persisted (up to 784 μM) without tyrosine elevation. Plasma total homocysteine was very slightly elevated for an infant to 14.5–15.9 μM. In plasma, S-adenosylmethionine was 30-fold and AdoHcy 150-fold elevated. Activity of AdoHcy hydrolase was ≈3% of control in liver and was 5–10% of the control values in red blood cells and cultured fibroblasts. We found no evidence of a soluble inhibitor of the enzyme in extracts of the patients cultured fibroblasts. Additional pretreatment abnormalities in plasma included low concentrations of phosphatidylcholine and choline, with elevations of guanidinoacetate, betaine, dimethylglycine, and cystathionine. Leukocyte DNA was hypermethylated. Gene analysis revealed two mutations in exon 4: a maternally derived stop codon, and a paternally derived missense mutation. We discuss reasons for biochemical abnormalities and pathophysiological aspects of AdoHcy hydrolase deficiency.


Journal of Inherited Metabolic Disease | 2005

S-Adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy

Ivo Barić; Mario Ćuk; K. Fumić; Oliver Vugrek; Robert H. Allen; B. Glenn; M. Maradin; Leo Pažanin; Igor P. Pogribny; Marko Radoš; Vladimir Sarnavka; Andreas Schulze; Sally P. Stabler; Conrad Wagner; Steven H. Zeisel; S. H. Mudd

SummaryS-Adenosylhomocysteine (AdoHcy) hydrolase deficiency has been proven in a human only once, in a recently described Croatian boy. Here we report the clinical course and biochemical abnormalities of the younger brother of this proband. This younger brother has the same two mutations in the gene encoding AdoHcy hydrolase, and has been monitored since birth. We report, as well, outcomes during therapy for both patients. The information obtained suggests that the disease starts in utero and is characterized primarily by neuromuscular symptomatology (hypotonia, sluggishness, psychomotor delay, absent tendon reflexes, delayed myelination). The laboratory abnormalities are markedly increased creatine kinase and elevated aminotransferases, as well as specific amino acid aberrations that pinpoint the aetiology. The latter include, most importantly, markedly elevated plasma AdoHcy. Plasma S-adenosylmethionine (AdoMet) is also elevated, as is methionine (although the hypermethioninaemia may be absent or nonsignificant in the first weeks of life). The disease seems to be at least to some extent treatable, as shown by improved myelination and psychomotor development during dietary methionine restriction and supplementation with creatine and phosphatidylcholine.


Journal of Inherited Metabolic Disease | 2006

Fumaric aciduria: Mild phenotype in a 8-year-old girl with novel mutations

Miljenka Maradin; Ksenija Fumić; Hana Hansikova; Marketa Tesarova; László Wenchich; Sanja Dorner; Vladimir Sarnavka; Jiri Zeman; Ivo Barić

SummaryFumaric aciduria is a rare, autosomal recessive disorder caused by deficient acitivity of fumarate hydratase (FH). Common clinical features are hypotonia, failure to thrive, severe psychomotor retardation and seizures. Facial dysmorphism and brain malformations are frequent. Recently, some FH gene mutations have been associated with inherited cutaneous and uterine leiomyomas and papillary renal cell cancer. Our patient had a relatively mild phenotype, a previously not reported genotype and familial tumour predisposition. The mother and grandmother had uterine myomas. The paternal grandfather and his two brothers died from lung and laryngeal cancers. The pregnancy was complicated by bleeding and intrauterine growth retardation. Delivery was after 35 weeks, with normal Apgar score. The girl was hypotonic since birth. At age 2 months the parents noticed short apnoeic crises. She could sit at age 1.5 years, and walk with assistance at 4 years. At age 8 years highly increased excretion of fumaric acid was found twice (217 and 445 mmol/mol creatinine). Shortly before that the girl started to have leg and arm spasms. Grand mal seizures occurred twice. Facial dysmorphism included depressed nasal bridge, anteverted ears, hypertelorism and microcephaly. Speech was limited to few disyllables. She was atactic with spastic paraparesis. Brain MRI showed slight ventriculomegaly, white-matter atrophy and hypoplasia of corpus callosum. Activity of FH in fibroblasts was 1.9 nmol/min/mg protein (controls 40–80). Analysis of the FH gene revealed the maternally derived c.1029_1031delAGT mutation, resulting in Val deletion and substitution of Gln by His, and paternally derived c.976C > T mutation, resulting in substitution of Pro by Ser.


Molecular Genetics and Metabolism | 2014

Newborn screening in southeastern Europe

Urh Groselj; Mojca Zerjav Tansek; Andraz Smon; Natalija Angelkova; Dana Anton; Ivo Barić; Maja Djordjevic; Lindita Grimci; Maria Ivanova; Adil Kadam; Vjosa Mulliqi Kotori; Hajrija Maksic; Oana Marginean; Otilia Margineanu; Olivera Milijanovic; Florentina Moldovanu; Mariana Muresan; Simona Murko; Michaela Nanu; Barbka Repic Lampret; Mira Samardzic; Vladimir Sarnavka; Aleksei Savov; Maja Stojiljkovic; Biljana Suzic; Radka Tincheva; Husref Tahirovic; Alma Toromanovic; Natalia Usurelu; Tadej Battelino

The aim of our study was to assess the current state of newborn screening (NBS) in the region of southeastern Europe, as an example of a developing region, focusing also on future plans. Responses were obtained from 11 countries. Phenylketonuria screening was not introduced in four of 11 countries, while congenital hypothyroidism screening was not introduced in three of them; extended NBS programs were non-existent. The primary challenges were identified. Implementation of NBS to developing countries worldwide should be considered as a priority.


Journal of Inherited Metabolic Disease | 2001

A new case of succinyl-CoA:acetoacetate transferase deficiency: favourable course despite very low residual activity.

Ivo Barić; Vladimir Sarnavka; Ksenija Fumić; Miljenka Maradin; D. Begović; Jos P.N. Ruiter; R. J. A. Wanders

Succinyl-CoA:acetoacetate transferase (SCOT) (EC 2.8.3.5) is a mitochondrial enzyme necessary for ketone body utilization in peripheral tissues. Its de¢ciency (McKusick 245050) has been reported in a limited number of patients and is characterized by recurrent ketoacidotic crises that can be life threatening (Niezen-Koning et al 1997; Snyderman et al 1998). Here we report a new patient whose clinical course thus far is benign despite very low residual activity. Our female patient, the ¢rst child of healthy nonconsanguineous parents, was born after a normal pregnancy. Birth length was 52 cm and weight 3500 g. Delivery was complicated by mild asphyxia, but her early physical and psychomotor development was normal. She was referred to our department at 6 months of age because of sopor and severe metabolic acidosis (pH 6.9, HCO3 3.2 mmol/L, BE ÿ27), which developed gradually during a period of two days of poor nutrition and unsuccessful attempts at rehydration and correction of acidosis in a regional hospital. No provocative factor could be identi¢ed. Apart from sopor and Kussmaul breathing with an acetone smell, her physical status was normal. Dipstick analysis showed strongly positive urinary ketone bodies. Blood glucose was slightly elevated; ammonia and lactate were normal. Urinary organic acids revealed only severe ketosis, together with repeated mild to moderate 4-hydroxybutyric aciduria, which remained unexplained and disappeared following resolution of crisis. Brain CT scan showed mild to moderate cortical atrophy. After two days of glucose, electrolytes and bicarbonate infusions, the girl recovered completely, but urinary ketones remained almost always weakly positive, suggesting a defect in the utilization of ketone bodies. A six-hour fast resulted in compensated metabolic acidosis (pH 7.42, HCO3 12.6 mmol/L, BE ÿ9.1), high serum ketone bodies of 3.55 mmol/L (upper normal limit 0.2 mmol/L in fed state and 1 mmol/L after 15-hour fast), low free fatty acids of 0.29 mmol/L and very low free fatty acids/3-hydroxybutyrate ratio of 0.09 (normal 0.9^4.3 after 15-hour fast), supporting the suspicion. SuccinylCoA:acetoacetate transferase activity in ¢broblasts was 0.1 nmol/min per mg


Neuropediatrics | 2009

POMT1-Associated Walker-Warburg Syndrome: A Disorder of Dendritic Development of Neocortical Neurons

Miloš Judaš; Goran Sedmak; Marko Radoš; Vladimir Sarnavka; Ksenija Fumić; Tobias Willer; Claudia Gross; Ute Hehr; Sabine Strahl; Martin Ćuk; Ivo Barić

We have analyzed the morphology and dendritic development of neocortical neurons in a 2.5-month-old infant with Walker-Warburg syndrome homozygotic for a novel POMT1 gene mutation, by Golgi methods. We found that pyramidal neurons frequently displayed abnormal (oblique, horizontal, or inverted) orientation. A novel finding of this study is that members of the same population of pyramidal neurons display different stages of development of their dendritic arborizations: some neurons had poorly developed dendrites and thus resembled pyramidal neurons of the late fetal cortex; for some neurons, the level of differentiation corresponded to that in the newborn cortex; finally, some neurons had quite elaborate dendritic trees as expected for the cortex of 2.5-month-old infant. In addition, apical dendrites of many pyramidal neurons were conspiciously bent to one side, irrespective to the general orientation of the pyramidal neuron. These findings suggest that Walker-Warburg lissencephaly is characterized by two hitherto unnoticed pathogenetic changes in the cerebral cortex: (a) heterochronic decoupling of dendritic maturation within the same neuronal population (with some members significantly lagging behind the normal maturational schedule) and (b) anisotropically distorted shaping of dendritic trees, probably caused by patchy displacement of molecular guidance cues for dendrites in the malformed cortex.


Orphanet Journal of Rare Diseases | 2015

Phenylketonuria screening and management in southeastern Europe – survey results from 11 countries

Mojca Zerjav Tansek; Urh Groselj; Natalija Angelkova; Dana Anton; Ivo Barić; Maja Djordjevic; Lindita Grimci; Maria Ivanova; Adil Kadam; Vjosa Mulliqi Kotori; Hajrija Maksic; Oana Marginean; Otilia Margineanu; Olivera Miljanovic; Florentina Moldovanu; Mariana Muresan; Michaela Nanu; Mira Samardzic; Vladimir Sarnavka; Aleksei Savov; Maja Stojiljkovic; Biljana Suzic; Radka Tincheva; Husref Tahirovic; Alma Toromanovic; Natalia Usurelu; Tadej Battelino

BackgroundWe aimed to assess the current state of PKU screening and management in the region of southeastern Europe.MethodsA survey was performed involving all identified professionals responsible for the PKU management in the 11 countries from South-Eastern region of Europe (Albania, Bulgaria, Bosnia and Herzegovina, Croatia, Kosovo, Macedonia, Moldova, Montenegro, Romania, Serbia, Slovenia). The questionnaire was designed to assess the characteristics regarding PKU management in three main areas: nation-wide characteristics, PKU screening, and characteristics of the PKU management in the responding centre. It consisted of 56 questions. The distribution and collection of the questionnaires (via e-mail) was taking place from December 2013 to March 2014.ResultsResponses from participants from 11 countries were included; the countries cumulative population is approx. 52.5 mio. PKU screening was not yet introduced in 4 of 11 countries. Reported PKU incidences ranged from 1/7325 to 1/39338 (and were not known for 5 countries). National PKU guidelines existed in 5 of 11 countries and 7 of 11 countries had PKU registry (registries included 40 to 194 patients). The number of PKU centers in each country varied from 1 to 6. Routine genetic diagnostics was reported in 4 of 11 countries. Most commonly used laboratory method to assess phenylalanine levels was fluorometric. Tetrahydrobiopterine was used in only 2 of 11 countries. Most frequently, pediatricians were caring for the patients. Dietitian was a member of PKU team in only 4 of 11 countries, while regular psychological assessments were performed in 6 of 11 countries. Patient’s PKU society existed in 7 of 11 countries.ConclusionsThe region of southeastern Europe was facing certain important challenges of PKU screening and management. Neonatal PKU screening should be introduced throughout the region. Furthermore, PKU management was falling behind internationally established standards-of-care in many aspects.


Clinical Chemistry and Laboratory Medicine | 1998

Molecular analysis and electromyoneurographic abnormalities in Croatian children with proximal spinal muscular atrophies

Nina Barišić; Jadranka Sertić; Christopher Billi; Ivo Barić; Vladimir Sarnavka; Tomislav Babić; Pero Hrabač; Davor Begović; Lina Florentin; Ana Stavljenić-Rukavina

Abstract Childhood onset proximal spinal muscular atrophy presents with considerable clinical variability. This study included 14 Croatian children aged 11 days to 8 years with spinal muscular atrophy types I-III verified clinically and electromyoneurographically. DNA of affected children was screened for deletions of exons 7 and 8 of the survival motor neuron gene and for deletion of exon 5 of the neuronal apoptosis inhibitor protein gene. Motor nerve conduction velocity and compound muscle action potential amplitude were decreased in children with spinal muscular atrophy type I and II. Deletions of exons 7 and 8 of the survival motor neuron gene and of exon 5 of the neuronal apoptosis inhibitor protein gene in children with spinal muscular atrophy type I-II suggested existence of more genetic abnormalities as compared to type III. A decrease in compound muscle action potential amplitude and motor nerve conduction velocity in children with spinal muscular atrophy correlated with the disease severity, probably as a result of axonal degeneration. Phenotypic severity in children onset spinal muscular atrophy is directly correlated with the extent of survival motor neuron and neuronal apoptosis inhibitor protein exon deletions.


Journal of Pediatric Endocrinology and Metabolism | 2016

Hyperinsulinism-hyperammonemia syndrome : a de novo mutation of the GLUD1 gene in twins and a review of the literature

Dorotea Ninković; Vladimir Sarnavka; Anica Bašnec; Mario Ćuk; Danijela Petković Ramadža; Ksenija Fumić; Vesna Kušec; René Santer; Ivo Barić

Abstract Hyperinsulinism-hyperammonemia (HI/HA) syndrome is a rare autosomal dominant disease characterized by recurrent hypoglycemia and persistent mild elevation of plasma ammonia. HI/HA syndrome is one of the more common forms of congenital hyperinsulinism (CHI), caused by activating mutations within the GLUD1 gene that encodes the mitochondrial enzyme glutamate dehydrogenase (GDH). We report here on monozygotic twin girls presented with fasting- and protein-induced hypoglycemia and mild persistent hyperammonemia. Genetic analysis revealed that both girls were heterozygous for a novel missense mutation within exon 11 [c.1499A>T, p.(R443W)] of the GLUD1 gene. Despite early treatment with diazoxide and a low protein diet, they both developed non-hypoglycemic seizures in early childhood followed by cognitive impairment. In addition to their clinical course, a review of the literature on HI/HA syndrome is provided.


Journal of Pediatric Endocrinology and Metabolism | 2018

Molecular basis and clinical presentation of classic galactosemia in a Croatian population

Danijela Petković Ramadža; Vladimir Sarnavka; Jurica Vuković; Ksenija Fumić; Vjekoslav Krželj; Bernarda Lozić; Silvija Pušeljić; Hana Pereira; Maria João Silva; Isabel Tavares de Almeida; Ivo Barić; Isabel Rivera

Abstract Background: Classic galactosemia is an autosomal recessive disorder of galactose metabolism caused by severely decreased activity of galactose-1-phosphate uridylyltransferase (GALT) due to pathogenic mutations in the GALT gene. To date more than 330 mutations have been described, with p.Q188R and p.K285N being the most common in Caucasian populations. Although acute manifestations can be fully avoided by a galactose-restricted diet, chronic complications, such as neurological ones, cannot be prevented in a significant number of patients despite compliance with the dietary treatment. Methods: A cohort of 16 galactosemic Croatian patients, including one pair of siblings, was studied. Molecular characterization was performed by direct sequence analysis of the GALT gene. Results: Sixteen patients were analyzed and only four different mutations were detected. As expected, p.Q188R and p.K285N were common, accounting for 40% and 37% of unrelated alleles, respectively. The third mutation accounting for 20% of mutant alleles was p.R123X causing a premature stop codon, is thus considered to be severe, which is in accordance with the phenotype presented by the homozygous patient described here. The fourth mutation p.E271D was found in a single allele. More than half of our patients manifested some chronic neurological complications. Conclusions: This is the first report on mutational and phenotypic spectra of classic galactosemia in Croatia that expands the knowledge on the mutational map of the GALT gene across Europe and reveals the genetic homogeneity of the Croatian population.

Collaboration


Dive into the Vladimir Sarnavka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge